Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Pfizer's Quiet Cash Comeback
09:50am, Tuesday, 03'rd Mar 2026
Pfizer delivers a 75.81% gross margin and 41.05% EBITDA margin, dramatically outperforming sector medians of 59.35% and 10.40%. Management targets $1.3 billion in net cost savings by 2026, reinforcing
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
08:10am, Tuesday, 03'rd Mar 2026
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
Becker Capital Management Inc. Cuts Holdings in Pfizer Inc. $PFE
05:06am, Tuesday, 03'rd Mar 2026
Becker Capital Management Inc. decreased its position in Pfizer Inc. (NYSE: PFE) by 14.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and E
Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript
01:27pm, Monday, 02'nd Mar 2026
Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript
1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never Sell
12:15pm, Monday, 02'nd Mar 2026
The stock is down, but the good news is that it sports a fat dividend yield of 6.4%. Pfizer has been struggling lately, but it has a rich pipeline of drugs in development.
Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026?
12:00pm, Monday, 02'nd Mar 2026
Pfizer's PFE stock has risen 11% so far in 2026. The stock has also been consistently trading above its 50-day and 200-day simple moving averages (SMAs) since early January.
Pfizer CEO flags issues with FDA's vaccine leadership
11:14am, Monday, 02'nd Mar 2026
Pfizer CEO Albert Bourla on Monday flagged issues with the leadership of the U.S. Food and Drug Administration's vaccine department.
The High Dividend Yield Bull Market: 3 Compelling 6% Yields
04:51am, Monday, 02'nd Mar 2026
High-yield stocks are outperforming, with a clear rotation from growth to value driving strong returns for dividend-focused investors. Safe, high-yielding companies are still trading at discounts. The
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need
12:03pm, Sunday, 01'st Mar 2026
Regencell Bioscience's outrageous performance in the past year is baffling. Despite the stock's sharp rise, there is little to look forward to for the drugmaker.
14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)
08:10am, Sunday, 01'st Mar 2026
March's Large Cap Value (GASV) screen highlights 14 fair-priced, 'safer' dividend stocks, including Hafnia Ltd, IRSA Inversiones, and Weibo Corp, as actionable buys. Top ten GASV stocks are projected
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?
05:45am, Sunday, 01'st Mar 2026
Eli Lilly is the current leader in the GLP-1 weight-loss drug space. Investors have placed a high valuation on Lilly's stock.
APG Asset Management N.V. Sells 1,033,141 Shares of Pfizer Inc. $PFE
04:10am, Sunday, 01'st Mar 2026
APG Asset Management N.V. lowered its position in shares of Pfizer Inc. (NYSE: PFE) by 22.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission.
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
10:00am, Friday, 27'th Feb 2026
NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced positive results from the Phase 3 EV-3
Dana Investment Advisors Inc. Sells 36,261 Shares of Pfizer Inc. $PFE
04:54am, Friday, 27'th Feb 2026
Dana Investment Advisors Inc. lessened its stake in shares of Pfizer Inc. (NYSE: PFE) by 35.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commis
Pfizer Inc. $PFE Shares Acquired by Andra AP fonden
04:54am, Friday, 27'th Feb 2026
Andra AP fonden increased its holdings in shares of Pfizer Inc. (NYSE: PFE) by 22.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The
